Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Trump Selects Alex Azar to Serve as Secretary of Health and Human Services

Alex Azar

Washington, DC, November 14, 2017 — President Donald J. Trump yesterday announced his nomination of Alex Azar, a former pharmaceutical executive and a top health official during the George W. Bush administration, to lead the U.S. Department of Health and Human Services.

In announcing that he is nominating Azar to be secretary of the government’s largest civilian department, the president turned to a health policy insider and conservative thinker.

Azar spent a decade at Eli Lilly and Co., including five years as president of Lilly USA, its biggest affiliate, before stepping down in January to work as a health-care consultant.

He previously was HHS general counsel, then served for two years as the department’s second-in-command.

Republicans predicted that, if confirmed, Azar would pursue Trump’s goals to tilt health-care policies in a more conservative direction through executive action.

Leading Democratic health policy experts, while not sharing Azar’s views, said he is well qualified for the post. His ties to the drug industry drew some rapid criticism, however.

In announcing his decision on Monday, Trump tweeted that Azar “will be a star for better healthcare and lower drug prices!” He has a close rapport with the department’s top political appointees as well as Vice President Pence.

Azar has been highly critical of the Affordable Care Act, saying in interviews in recent months that the law was “certainly circling the drain” and that many of its problems “were entirely predictable as a matter of economic and individual behavior.”

In announcing the nomination on November 13, The White House said:

“As President of Lilly USA, LLC, the largest affiliate of global biopharmaceutical leader Eli Lilly and Company, he directly led the U.S. Biomedicines business unit, the affiliate’s largest division, encompassing the areas of neuroscience, cardiovascular health, men’s health, musculoskeletal, autoimmune disease, Alzheimer’s disease, and pain, as well as the sales, marketing, and payer operations of the company’s U.S. commercial business.

“Prior to his time at Lilly USA, Mr. Azar was the Deputy Secretary of the U.S. Department of Health and Human Services immediately after serving as its General Counsel, where the Senate confirmed him for both Presidential appointments by voice vote.

“He received his bachelor’s degree from Dartmouth College and his juris doctorate from Yale University.”